This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wheless, J. W. Articles by Ng, Y.-t. Search for Related Content PubMed PubMed Citation Articles by Wheless, J. W. Articles by Ng, Y.-t. Social Bookmarking                         What's this?

Levetiracetam in Refractory Pediatric Epilepsy

Departments of Neurology, Texas Comprehensive Epilepsy Program, University of Texas-Houston, Houston, TX, James.W.Wheless{at}uth.tmc.edu

Yu-tze Ng, MBBS, FRACP

Departments of Pediatrics, Texas Comprehensive Epilepsy Program, University of Texas-Houston, Houston, TX

Levetiracetam, one of the newer-generation antiepilepsy drugs, is not currently approved for use in children. Given its favorable efficacy, pharmacokinetic, and, particularly, safety profile in adults, we felt that it may be a useful antiepilepsy drug for children with refractory epilepsy. We treated 39 patients (mean age 8.6 years) with open-label levetiracetam for up to 9 months. Seizure frequency, drug dosages, adverse events, and neurologic examinations were documented at baseline and routine follow-up visits. Levetiracetam, as add-on therapy, was effective in reducing seizure frequency in a variety of seizure types but was most effective for partial-onset seizures. Fourteen patients were discontinued for lack of efficacy or adverse events. Ten patients reported improvements in cognition or behavior. Levetiracetam was generally effective and well tolerated in this open-label study. Its apparent positive effects on cognition in some patients are encouraging. Large, well-controlled studies are needed to fully define levetiracetam's potential in children with refractory epilepsy. (J Child Neurol 2002;17:413-415).

Journal of Child Neurology, Vol. 17, No. 6, 413-415 (2002)
DOI: 10.1177/088307380201700603


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				E. D'Agati, R. Moavero, C. Cerminara, and P. Curatolo Attention-Deficit Hyperactivity Disorder (ADHD) and Tuberous Sclerosis Complex J Child Neurol, October 1, 2009; 24(10): 1282 - 1287. [Abstract] [PDF]

				Z. Yang, X. Liu, J. Qin, Y. Zhang, X. Bao, and H. Xiong Partial Seizures and Atypical Absence Seizures as a Single Ictal Event in a Patient With Lennox-Gastaut Syndrome J Child Neurol, November 1, 2008; 23(11): 1319 - 1323. [Abstract] [PDF]

				M. T. Shoemaker and J. S. Rotenberg Levetiracetam for the Treatment of Neonatal Seizures J Child Neurol, January 1, 2007; 22(1): 95 - 98. [Abstract] [PDF]

				T. A. Glauser, R. Ayala, R. D. Elterman, W. G. Mitchell, C. B. Van Orman, L. J. Gauer, Z. Lu, and on behalf of the N159 Study Group Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures Neurology, June 13, 2006; 66(11): 1654 - 1660. [Abstract] [Full Text] [PDF]

				J. J. Collins, C. Tudor, J. M. Leonard, G. Chuck, and D. N. Franz Levetiracetam as Adjunctive Antiepileptic Therapy for Patients with Tuberous Sclerosis Complex: A Retrospective Open-Label Trial J Child Neurol, January 1, 2006; 21(1): 53 - 57. [Abstract] [PDF]

				D. E. Mandelbaum, M. Bunch, S. L. Kugler, A. Venkatasubramanian, and J. B. Wollack Efficacy of Levetiracetam at 12 Months in Children Classified by Seizure Type, Cognitive Status, and Previous Anticonvulsant Drug Use J Child Neurol, July 1, 2005; 20(7): 590 - 594. [Abstract] [PDF]

				F. Vigevano Topical Review: Levetiracetam in Pediatrics J Child Neurol, February 1, 2005; 20(2): 87 - 93. [Abstract] [PDF]

				J. Cavitt and M. Privitera Levetiracetam Induces a Rapid and Sustained Reduction of Generalized Spike-Wave and Clinical Absence Arch Neurol, October 1, 2004; 61(10): 1604 - 1607. [Abstract] [Full Text] [PDF]

				J. M. Pellock The Challenge of Neuropsychiatric Issues in Pediatric Epilepsy J Child Neurol, August 1, 2004; 19(1_suppl): S1 - S5. [Abstract] [PDF]

				T. A. Glauser Behavioral and Psychiatric Adverse Events Associated With Antiepileptic Drugs Commonly Used in Pediatric Patients J Child Neurol, August 1, 2004; 19(1_suppl): S25 - S38. [Abstract] [PDF]

				J. W. Wheless and B. F. D. Bourgeois Choosing Antiepileptic Drugs for Developmentally Normal Children With Specific Epilepsy Syndromes and Behavioral Disorders J Child Neurol, August 1, 2004; 19(1_suppl): S39 - S48. [Abstract] [PDF]

				D. W. Loring and K. J. Meador Cognitive side effects of antiepileptic drugs in children Neurology, March 23, 2004; 62(6): 872 - 877. [Abstract] [Full Text] [PDF]

				J. M. Pellock The Challenge of Neuropsychiatric Issues in Pediatric Epilepsy J Child Neurol, January 1, 2004; 19(1_suppl): S1 - S5. [Abstract] [PDF]

				T. A. Glauser Behavioral and Psychiatric Adverse Events Associated With Antiepileptic Drugs Commonly Used in Pediatric Patients J Child Neurol, January 1, 2004; 19(1_suppl): S25 - S38. [Abstract] [PDF]

				J. W. Wheless and B. F. D. Bourgeois Choosing Antiepileptic Drugs for Developmentally Normal Children With Specific Epilepsy Syndromes and Behavioral Disorders J Child Neurol, January 1, 2004; 19(1_suppl): S39 - S48. [Abstract] [PDF]